Same-day chemo may enhance cancer vaccine efficacy in preclinical studies

Chemotherapy’s harsh side effects, such as hair loss and gastrointestinal distress, arise from its impact on rapidly dividing cells, including immune cells critical for fighting cancer.

A new preclinical study explores how timing chemotherapy with cancer vaccines might amplify the immune system’s response to tumors, potentially improving treatment outcomes.

Researchers found that administering chemotherapy and vaccines on the same day in laboratory models could enhance the activity of CD8+ T cells, which are essential for targeting cancer cells.

While these findings are promising, experts emphasize that further research is needed before such an approach can be tested in human trials.

Based on reporting from Medical Xpress (Cancer).

Source: Medical Xpress (Cancer). This article was drafted by AI from that reporting and reviewed by an automated accuracy check before publishing.